par Callie Weber | Mar 13, 2024 | Access to Care, NCD Partnerships, Actualités
In a significant stride towards addressing the global challenge of Noncommunicable Diseases (NCDs), IDA Foundation and the Coalition for Access to NCD Medicines & Products are proud to announce their partnership. NCDs, encompassing chronic conditions such as...
par Callie Weber | Fév 9, 2024 | NCD Partnerships, NCD Solutions, Actualités
Have you heard about NCDconnect? Through the innovative NCDconnect platform, IDA Foundation and Solvoz have formed a strategic partnership, united in their mission to streamline the procurement of high-quality NCD medicines, medical supplies, and diagnostics. Serving...
par Agathe Masson | Fév 5, 2024 | Access to Care, NCD Partnerships, Actualités
IDA Foundation and the Access to Oncology Medicines (ATOM) Coalition are happy to announce their strategic partnership. Following World Cancer Day’s theme ‘Close the Care Gap’, this collaboration marks a significant step toward addressing the challenges of...
par Agathe Masson | Jan 15, 2024 | Access to Care, Healthcare Systems, Actualités
The global impact of cervical cancer is staggering, with approximately 660,000 new cases recorded in 2022, resulting in 350,000 deaths – 94% of which occurred in low- and middle-income countries (LMICs). [Explore the WHO’s dedicated page on Cervical Cancer for...
par Callie Weber | Jan 8, 2024 | Access to Care, NCD Policy, Actualités
Counterfeit and substandard medicine trafficking is one of the world’s fastest-growing and highest-value criminal enterprises. Analysts estimate the global counterfeit market to be worth between US$200 and $432 billion. Since the issue first came to light in a 2003...
par Agathe Masson | Déc 15, 2023 | Access to Care, NCD Solutions, Actualités
Noncommunicable diseases (NCDs) present a global health crisis, exacerbated by the COVID-19 pandemic. These diseases, including cancer, cardiovascular diseases, diabetes, and chronic respiratory illnesses, claim a staggering 41 million lives every year. That is 74% of...
